Steven Nissen

Type: Person

Name: Steven Nissen

First reported May 07 2013 - Updated May 08 2013 - 1 reports

Surprise as Merck & Co cholesterol combo gets FDA OK

The US Food and Drug Administration has controversially given the green light to Merck & Co's Liptruzet, a combination of the company’s Zetia and Pfizer's off-patent cholesterol-lower Lipitor.The agency has approved Liptruzet (ezetimibe and atorvastatin) ... [Published Pharma Times - May 07 2013]

Entities: Cholesterol, Lipitor, Merck & Co Inc, Zetia, Steven Nissen

First reported May 05 2013 - Updated May 05 2013 - 1 reports

Merck & Co Inc

FDA Approves Cholesterol Drug Liptruzet

The United States Food and drug Administration has announced the approval on Friday of a drug developed by Merck that reduces a person’s cholesterol. Liptruzet is a combination drug that combines Merck’s Zetia and the generic form of Pfizer’s Lipitor. ... [Published StudentNews.ie - May 05 2013]

Entities: Cholesterol, Drugs, Zetia, Merck & Co Inc

First reported May 03 2013 - Updated May 04 2013 - 1 reports

Lipitor

Merck's Cholesterol Pill Win Is Already Drawing Fire

The Food and Drug Administration just approved Liptruzet, a new cholesterol-lowering pill that combines the generically available ingredient available in Pfizerâs Lipitor with Merckâs Zetia. Merck has been working to get the combination pill approved ... [Published Forbes.com - May 03 2013]

Entities: Zetia, Simvastatin, Lipitor, Cholesterol

First reported Apr 25 2013 - Updated Apr 25 2013 - 1 reports

Experienced biotech team snags $33M for promising PhII cholesterol drug

Now that the successful biopharma team of Roger Newton and Tim Mayleben has reunited to run an upstart--Esperion--with a promising mid-stage cholesterol drug in the pipeline, some well-known names in the venture crowd have decided to tag along and see ... [Published FierceBiotech - Apr 25 2013]

Entities: Cholesterol, Drugs, Biotechnology

First reported Apr 13 2013 - Updated Apr 13 2013 - 1 reports

GlaxoSmithKline plc

Avandia Again Focus of FDA Review

Earn Free CME Credits by reading the latest medical news in your specialty.Sign UpLatest News| VideosWASHINGTON -- The FDA will review results of the latest "independent readjudication" of the study that formed the basis for its original approval of rosiglitazone ... [Published MedPage Today - Apr 13 2013]

Entities: Avandia, rosiglitazone, Drugs, Neurology, GlaxoSmithKline plc

Quotes

"A 20% lowering of LDL cholesterol is clinically meaningful," says Steven Nissen, chairman of cardiology at the Cleveland Clinic. "at the very least we can reduce the need for apheresis in these patients."

Wall Street Gets It Backward On Amgen Cholesterol Drug [Published Forbes.com - Apr 30 2013]

"obviously it’s very early, but the drug does all the right things: lower ldl, lower triglycerides" says Steven Nissen, the chairman of the cardiology department at the Cleveland Clinic

Emerging Cholesterol Pill Could Compete With Amgen, Aegerion [Published Forbes.com - Apr 25 2013]

"if those guidelines are produced in a way that is not completely free of bias, then we are guiding physicians and patients toward therapies based on opinions that may have been influenced by people's financial relationships" Nissen said. "That is a huge problem."

The hidden hand [Published PharmaGossip - Dec 19 2012]

More Content

sort by: Date \| Relevance
Surprise as Merck & Co cholesterol combo gets F... [Published Pharma Times - May 07 2013]
FDA Approves Cholesterol Drug Liptruzet [Published StudentNews.ie - May 05 2013]
Merck's Cholesterol Pill Win Is Already Drawing... [Published Forbes.com - May 03 2013]
Wall Street Gets It Backward On Amgen Cholester... [Published Forbes.com - Apr 30 2013]
Experienced biotech team snags $33M for promisi... [Published FierceBiotech - Apr 25 2013]
Emerging Cholesterol Pill Could Compete With Am... [Published Forbes.com - Apr 25 2013]
News from the American College of Cardiology Sc... [Published British Journal of Cardiology - Apr 23 2013]
Avandia Again Focus of FDA Review [Published MedPage Today - Apr 13 2013]
The Fight to Rescue American Health Care [Published CNN.com - Video - Mar 08 2013]
The hidden hand [Published PharmaGossip - Dec 19 2012]
Honest research vs. drug company bias [Published Bend Bulletin - Dec 02 2012]
A Lean Thinker Watches the Documentary “Escape ... [Published Lean Blog - Nov 27 2012]
Heart treatment has controversial study [Published WCPO - Nov 05 2012]